Last reviewed · How we verify

NCT05368909

Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality

Completed NA Last updated 12 July 2022
What this trial tests

NA trial testing Sleep Supplement in Sleep Quality in 30 participants. Completed in 31 May 2022.

Timeline
16 December 2021
Primary endpoint
28 March 2022
31 May 2022

Quick facts

Lead sponsor4Life Research, LLC
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment30
Start date16 December 2021
Primary completion28 March 2022
Estimated completion31 May 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

4Life Research, LLC

Who can join

Adults 18 to 60, any sex, with Sleep Quality or Sleep Health. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate the effects of a proprietary oral supplement on the sleep health and quality of people with sleep problems. It is a double-blinded placebo-controlled crossover clinical study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sleep Supplement

Trials testing the same drug.

Other recruiting trials for Sleep Quality

Currently open trials in the same condition.

Other 4Life Research, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05368909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing